Clinical trial

Comparison Of The Outcome Of Treatment of Microneedling With Autologous Platelet- Rich -Plasma Versus Microneedling With Topical Insulin In The Treatment Of Post Acne Atrophic Scars.

Name
NO.F.2-81/2022-GENL/252/JPMC
Description
Microneedling with topical INSULIN is a simple, effective tool for building body's new collagen layers and thus an alternative to all erosive techniques such as lasers, peels. The skin responds to fine punctures with the release of growth factors. 8 It is a safe procedure that can be performed in the office without complications, with a good cost-benefit because it is economically viable without any effect on patient's daily activities. 9
Trial arms
Trial start
2022-08-01
Estimated PCD
2022-12-01
Trial end
2023-02-01
Status
Completed
Phase
Early phase I
Treatment
PRP( platelet rich plasma) and Insulin human
Microneedling with autologus PRP reduces inflammationin acne scars. Insulin human is a new topical drug which is used nowadays for acne scars as it is more effective in producing collagen formation as well as new blood vessel formation
Arms:
GROUP A Microneedling with PRP(platelete rich plasma), GROUP B Microneedling with topical INSULIN
Size
50
Primary endpoint
Efficacy of Topical Insulin R with microneedling versus Platelets rich plasma in atrophic acne scars
Efficacy will be assesed upto 4 months.
Eligibility criteria
Inclusion Criteria: * postacne atrophic scars ≥ 2 on Goodman and Baron's acne scar-grading system * Either gender. * Age 20-50 years. Exclusion Criteria: * lactation and pregnancy * skin cancers and infection * photosensitivity like SLE ,XP * use of RETINOIDS in last 6 months.
Protocol
{'studyType': 'INTERVENTIONAL', 'phases': ['PHASE2'], 'designInfo': {'allocation': 'RANDOMIZED', 'interventionModel': 'PARALLEL', 'primaryPurpose': 'TREATMENT', 'maskingInfo': {'masking': 'NONE'}}, 'enrollmentInfo': {'count': 50, 'type': 'ACTUAL'}}
Updated at
2023-08-21

1 organization

1 product

1 indication